GleamWall
中文EN

IRIX IRIDEX CORP

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1006045 · Fiscal year ends 01/03

Financial factors as of 2026-10-03 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-2.8%
TTM net income YoY33.7%
TTM EPS YoY36.7%
Revenue 3-yr CAGR-3.4%
Net income 3-yr CAGR—

Margins

Gross margin38.2%
Operating margin-5.1%
Net margin-6.9%
FCF margin-3.7%
EBITDA margin-4.2%

Returns

ROE-92.4%
ROA-11.7%
ROIC (approx.)—
Asset turnover1.71x

Leverage & solvency

Liabilities / assets91.0%
Debt / equity0.00x
Current ratio1.76x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.45x
Accruals ratio-6.5%
Payout ratio—
Capex / revenue0.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-10-032026Q22026-07-042026Q12026-04-042026Q4*2026-01-032025Q32025-09-272025Q22025-06-282025Q12025-03-292024Q4*2024-12-28
Income statement
Revenue$10.16M$12.57M$11.80M$14.72M$12.48M$13.57M$11.90M$12.70M
Cost of revenue$5.85M$8.27M$7.06M$9.25M$8.47M$8.89M$6.84M$7.11M
Gross profit$4.30M$4.30M$4.74M$5.48M$4.01M$4.68M$5.05M$5.59M
R&D expense$1.01M$936,000$905,000$949,000$972,000$871,000$876,000$1.11M
SG&A expense$2.04M$1.84M$1.62M$1.79M$1.79M$2.22M$1.93M$2.27M
Operating income-$1.16M-$1.03M-$324,000-$15,000-$1.41M-$940,000-$205,000-$502,000
Interest expense———————$88,000
Pretax income-$1.32M-$1.20M-$466,000-$164,000-$1.57M-$973,000-$1.67M-$840,000
Income tax$78,000$70,000$58,000$20,000$4,000$21,000$12,000-$6,000
Net income-$1.40M-$1.27M-$524,000-$184,000-$1.57M-$994,000-$1.69M-$834,000
EBITDA-$1.04M-$943,000-$224,000$136,000-$1.30M-$813,000-$70,000-$367,000
EPS (basic)-0.08-0.07-0.03—-0.09-0.06-0.10—
EPS (diluted)-0.08-0.07-0.03—-0.09-0.06-0.10—
Weighted avg. shares (diluted)17.59M17.42M17.31M—17.01M16.79M16.73M—
Balance sheet
Cash & equivalents$3.67M$4.68M$4.59M$6.03M$5.57M$6.78M$7.24M$2.39M
Receivables$4.20M$5.67M$6.84M$7.61M$7.13M$7.14M$6.68M$5.95M
Inventory$11.76M$9.75M$9.32M$7.88M$7.30M$8.44M$10.14M$10.82M
Current assets$22.82M$23.96M$24.58M$25.25M$24.07M$26.87M$29.13M$23.56M
PP&E, net$210,000$182,000$139,000$58,000$23,000$40,000$75,000$115,000
Goodwill$965,000$965,000$965,000$965,000$965,000$965,000$965,000$965,000
Intangibles$745,000$825,000$904,000$984,000$1.06M$1.14M$1.22M$1.31M
Total assets$29.27M$27.26M$28.27M$29.15M$28.35M$31.59M$34.24M$29.14M
Current liabilities$12.99M$13.17M$12.83M$13.21M$12.39M$13.71M$14.95M$16.56M
Short-term debt———————$1.70M
Long-term debt———————$1.00M
Total debt———————$2.70M
Total liabilities$26.64M$23.62M$23.54M$24.23M$23.67M$25.53M$27.38M$27.04M
Shareholders' equity$2.63M$3.64M$4.73M$4.92M$4.68M$6.06M$852,000$2.10M
Net debt———————$313,000
Shares outstanding17.81M17.45M17.40M17.31M17.05M16.81M16.79M16.64M
Cash flow statement
Operating cash flow-$942,000$174,000-$1.33M$589,000-$1.16M-$397,000-$1.15M-$1.24M
Capital expenditure$29,000$50,000$101,000$106,000$13,000$13,000$11,000$9,000
Free cash flow-$971,000$124,000-$1.44M$483,000-$1.17M-$410,000-$1.16M-$1.25M
Investing cash flow-$29,000-$50,000-$101,000-$106,000-$13,000-$13,000-$11,000-$9,000
Financing cash flow-$33,000-$38,000-$1,000-$27,000-$34,000-$14,000$6.04M-$218,000
Depreciation & amortization$127,000$86,000$100,000$151,000$110,000$127,000$135,000$135,000
Stock-based compensation$182,000$212,000$211,000$213,000$92,000$257,000$213,000$316,000

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.